| Financial Year |
March 31 2023 |
| Monetary Funds |
1,346,998,738.47 |
| Held-for-trading Financial Assets |
13,576,538.39 |
| Notes Receivable |
719,661,996.21 |
| Accounts Receivable |
2,013,855,413.17 |
| Advances to Suppliers |
91,643,885.33 |
| Other Receivables |
44,510,702.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,436,027,940.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
112,335,408.34 |
| Total Current Assets |
7,562,995,247.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
120,286,137.65 |
| Investment Properties |
14,804,536.71 |
| Fixed Assetes |
3,184,124,639.19 |
| Under-construction Projects |
558,596,948.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
398,668,897.24 |
| R&D expenses |
-- |
| Goodwill |
12,147,367.88 |
| Long-Term Deferred and Prepaid Expenses |
19,888,077.89 |
| Deferred Income Tax Assets |
203,292,743.57 |
| Other Non-Current Assets |
1,036,566,227.10 |
| Sub-Total of Non-Current Assets |
5,724,448,844.53 |
| Total Assets |
13,287,444,091.91 |
| Short-Term Loans |
683,861,482.85 |
| Trading Financial liabilities |
145,210.86 |
| Notes Payable |
2,173,947,320.05 |
| Accounts Payable |
2,633,815,427.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
130,337,053.49 |
| Taxes Payable |
69,222,922.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
106,811,447.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,848,376.32 |
| Other Current Liabilities |
615,300,165.82 |
| Sub-Total of Current Liabilities |
6,883,008,762.31 |
| Long-term Loans |
1,161,916,948.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
173,066,870.44 |
| Deferred Income Tax Liabilities |
139,864,638.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,997,104,489.18 |
| Total Liabilities |
8,880,113,251.49 |
| Paid-In Capital(Or Share Stock) |
461,291,966.00 |
| Capital Surplus |
1,631,789,038.32 |
| Surplus Reserve |
75,197,102.33 |
| LESS:Treasury Stock |
12,252,099.64 |
| Undistributed Profits |
1,963,170,970.43 |
| Minority Stockholder's Interest |
251,996,603.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,155,334,237.24 |
| Owner's Equity（Stockholder's Equity） |
4,407,330,840.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,287,444,091.91 |
